Childhood survival in Haiti: Protective effect of measles vaccination

E. A. Holt, R. Boulos, Neal A Halsey, L. M. Boulos, C. Boulos

Research output: Contribution to journalArticle

Abstract

To evaluate the impact of measles vaccination on survival of children residing in a periurban slum in Haiti, a total-population survey was conducted 2.5 years after completion of a one-time study of the serologic response to measles vaccine administered in the same population. Pregnancy histories from the 16400 women in the population revealed that 1499 children had been born during a 7-month interval that would have made them eligible for participation in the measles vaccine program. Of these children, 1381 (92.1%) survived to 9 months of age, the median age that measles vaccine had been administered. Seventy-three infants had died between 9 and 39 months of age. Mortality of infants who were seronegative before receiving measles vaccine was significantly lower (P = .0013) than that of unvaccinated infants (3/235 vs 70/1056, respectively). Other factors positively associated with survival between 9 and 39 months of age included socioeconomic status (P = .0002), maternal literacy (P = .0020), maternal knowledge and use of oral rehydration solution (P = .0002), and an interval of greater than 24 months to the birth of the next younger sibling (P = .0012). Multivariate stepwise logistic regression analysis was used to evaluate the independent association of measles vaccination by adjusting for other factors that also correlated with survival and that might have been associated with maternal seeking of vaccinations. Children who survived were more likely to have received measles vaccine than children who died, independent of the effects from socioeconomic status, maternal knowledge of oral rehydration solution, maternal literacy, and birth interval (adjusted odds ratio = 6.5, 95% confidence interval 1.6 to 27.1). Estimates of the efficacy of measles vaccine for prevention of mortality from 9 through 39 months of age ranged from 84.7% to 90% by different methods of analysis. Therefore, measles vaccination appears to be an effective intervention for improving the survival of children residing in developing countries. Efforts should be increased to eliminate this disease from all countries.

Original languageEnglish (US)
Pages (from-to)188-194
Number of pages7
JournalPediatrics
Volume85
Issue number2
StatePublished - 1990
Externally publishedYes

Fingerprint

Haiti
Measles Vaccine
Measles
Vaccination
Mothers
Survival
Rehydration Solutions
Fluid Therapy
Social Class
Population
Birth Intervals
Poverty Areas
Reproductive History
Time and Motion Studies
Infant Mortality
Developing Countries
Siblings
Logistic Models
Odds Ratio
Regression Analysis

Keywords

  • diarrhea
  • measles
  • mortality
  • oral rehydration
  • vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Holt, E. A., Boulos, R., Halsey, N. A., Boulos, L. M., & Boulos, C. (1990). Childhood survival in Haiti: Protective effect of measles vaccination. Pediatrics, 85(2), 188-194.

Childhood survival in Haiti : Protective effect of measles vaccination. / Holt, E. A.; Boulos, R.; Halsey, Neal A; Boulos, L. M.; Boulos, C.

In: Pediatrics, Vol. 85, No. 2, 1990, p. 188-194.

Research output: Contribution to journalArticle

Holt, EA, Boulos, R, Halsey, NA, Boulos, LM & Boulos, C 1990, 'Childhood survival in Haiti: Protective effect of measles vaccination', Pediatrics, vol. 85, no. 2, pp. 188-194.
Holt EA, Boulos R, Halsey NA, Boulos LM, Boulos C. Childhood survival in Haiti: Protective effect of measles vaccination. Pediatrics. 1990;85(2):188-194.
Holt, E. A. ; Boulos, R. ; Halsey, Neal A ; Boulos, L. M. ; Boulos, C. / Childhood survival in Haiti : Protective effect of measles vaccination. In: Pediatrics. 1990 ; Vol. 85, No. 2. pp. 188-194.
@article{0fe6d7fb5db84978873bc056df2cf843,
title = "Childhood survival in Haiti: Protective effect of measles vaccination",
abstract = "To evaluate the impact of measles vaccination on survival of children residing in a periurban slum in Haiti, a total-population survey was conducted 2.5 years after completion of a one-time study of the serologic response to measles vaccine administered in the same population. Pregnancy histories from the 16400 women in the population revealed that 1499 children had been born during a 7-month interval that would have made them eligible for participation in the measles vaccine program. Of these children, 1381 (92.1{\%}) survived to 9 months of age, the median age that measles vaccine had been administered. Seventy-three infants had died between 9 and 39 months of age. Mortality of infants who were seronegative before receiving measles vaccine was significantly lower (P = .0013) than that of unvaccinated infants (3/235 vs 70/1056, respectively). Other factors positively associated with survival between 9 and 39 months of age included socioeconomic status (P = .0002), maternal literacy (P = .0020), maternal knowledge and use of oral rehydration solution (P = .0002), and an interval of greater than 24 months to the birth of the next younger sibling (P = .0012). Multivariate stepwise logistic regression analysis was used to evaluate the independent association of measles vaccination by adjusting for other factors that also correlated with survival and that might have been associated with maternal seeking of vaccinations. Children who survived were more likely to have received measles vaccine than children who died, independent of the effects from socioeconomic status, maternal knowledge of oral rehydration solution, maternal literacy, and birth interval (adjusted odds ratio = 6.5, 95{\%} confidence interval 1.6 to 27.1). Estimates of the efficacy of measles vaccine for prevention of mortality from 9 through 39 months of age ranged from 84.7{\%} to 90{\%} by different methods of analysis. Therefore, measles vaccination appears to be an effective intervention for improving the survival of children residing in developing countries. Efforts should be increased to eliminate this disease from all countries.",
keywords = "diarrhea, measles, mortality, oral rehydration, vaccine",
author = "Holt, {E. A.} and R. Boulos and Halsey, {Neal A} and Boulos, {L. M.} and C. Boulos",
year = "1990",
language = "English (US)",
volume = "85",
pages = "188--194",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Childhood survival in Haiti

T2 - Protective effect of measles vaccination

AU - Holt, E. A.

AU - Boulos, R.

AU - Halsey, Neal A

AU - Boulos, L. M.

AU - Boulos, C.

PY - 1990

Y1 - 1990

N2 - To evaluate the impact of measles vaccination on survival of children residing in a periurban slum in Haiti, a total-population survey was conducted 2.5 years after completion of a one-time study of the serologic response to measles vaccine administered in the same population. Pregnancy histories from the 16400 women in the population revealed that 1499 children had been born during a 7-month interval that would have made them eligible for participation in the measles vaccine program. Of these children, 1381 (92.1%) survived to 9 months of age, the median age that measles vaccine had been administered. Seventy-three infants had died between 9 and 39 months of age. Mortality of infants who were seronegative before receiving measles vaccine was significantly lower (P = .0013) than that of unvaccinated infants (3/235 vs 70/1056, respectively). Other factors positively associated with survival between 9 and 39 months of age included socioeconomic status (P = .0002), maternal literacy (P = .0020), maternal knowledge and use of oral rehydration solution (P = .0002), and an interval of greater than 24 months to the birth of the next younger sibling (P = .0012). Multivariate stepwise logistic regression analysis was used to evaluate the independent association of measles vaccination by adjusting for other factors that also correlated with survival and that might have been associated with maternal seeking of vaccinations. Children who survived were more likely to have received measles vaccine than children who died, independent of the effects from socioeconomic status, maternal knowledge of oral rehydration solution, maternal literacy, and birth interval (adjusted odds ratio = 6.5, 95% confidence interval 1.6 to 27.1). Estimates of the efficacy of measles vaccine for prevention of mortality from 9 through 39 months of age ranged from 84.7% to 90% by different methods of analysis. Therefore, measles vaccination appears to be an effective intervention for improving the survival of children residing in developing countries. Efforts should be increased to eliminate this disease from all countries.

AB - To evaluate the impact of measles vaccination on survival of children residing in a periurban slum in Haiti, a total-population survey was conducted 2.5 years after completion of a one-time study of the serologic response to measles vaccine administered in the same population. Pregnancy histories from the 16400 women in the population revealed that 1499 children had been born during a 7-month interval that would have made them eligible for participation in the measles vaccine program. Of these children, 1381 (92.1%) survived to 9 months of age, the median age that measles vaccine had been administered. Seventy-three infants had died between 9 and 39 months of age. Mortality of infants who were seronegative before receiving measles vaccine was significantly lower (P = .0013) than that of unvaccinated infants (3/235 vs 70/1056, respectively). Other factors positively associated with survival between 9 and 39 months of age included socioeconomic status (P = .0002), maternal literacy (P = .0020), maternal knowledge and use of oral rehydration solution (P = .0002), and an interval of greater than 24 months to the birth of the next younger sibling (P = .0012). Multivariate stepwise logistic regression analysis was used to evaluate the independent association of measles vaccination by adjusting for other factors that also correlated with survival and that might have been associated with maternal seeking of vaccinations. Children who survived were more likely to have received measles vaccine than children who died, independent of the effects from socioeconomic status, maternal knowledge of oral rehydration solution, maternal literacy, and birth interval (adjusted odds ratio = 6.5, 95% confidence interval 1.6 to 27.1). Estimates of the efficacy of measles vaccine for prevention of mortality from 9 through 39 months of age ranged from 84.7% to 90% by different methods of analysis. Therefore, measles vaccination appears to be an effective intervention for improving the survival of children residing in developing countries. Efforts should be increased to eliminate this disease from all countries.

KW - diarrhea

KW - measles

KW - mortality

KW - oral rehydration

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=0025092025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025092025&partnerID=8YFLogxK

M3 - Article

C2 - 2296506

AN - SCOPUS:0025092025

VL - 85

SP - 188

EP - 194

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -